Investor profile

Scion Asset Management

Compact public equity portfolio disclosed through quarterly Form 13F filings.

Latest filing: Nov 3, 2025 Source: SEC 13F Research only

Daily return+5.3%

YTD return-3.2%

Drawdown0.0%

Holdings8

Basket Return Estimate

Indexed price mark of the latest disclosed holdings with mapped tickers.

Return history will appear after the daily return cron has enough price data for this tracker.

Recent Filing Events

Changes detected versus the prior filing.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

LAUDER ESTEE COS INC was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ASML HOLDING N V was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ALIBABA GROUP HLDG LTD was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

LAUDER ESTEE COS INC was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ASML HOLDING N V was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ALIBABA GROUP HLDG LTD was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

LAUDER ESTEE COS INC was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ASML HOLDING N V was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

ALIBABA GROUP HLDG LTD was not present in the latest 13F information table.

Nov 3, 2025 · VFC Scion Asset Management no longer disclosed a prior position

VF Corporation was not present in the latest 13F information table.

Nov 3, 2025 · UNH Scion Asset Management no longer disclosed a prior position

UnitedHealth Group Incorporated was not present in the latest 13F information table.

Nov 3, 2025 · REGN Scion Asset Management no longer disclosed a prior position

Regeneron Pharmaceuticals Inc was not present in the latest 13F information table.

Nov 3, 2025 · META Scion Asset Management no longer disclosed a prior position

Meta Platforms, Inc. was not present in the latest 13F information table.

Nov 3, 2025 · MELI Scion Asset Management no longer disclosed a prior position

MercadoLibre Inc was not present in the latest 13F information table.

Nov 3, 2025 Scion Asset Management no longer disclosed a prior position

LAUDER ESTEE COS INC was not present in the latest 13F information table.

Nov 3, 2025 · 9618.HK Scion Asset Management no longer disclosed a prior position

JD.com was not present in the latest 13F information table.

Latest Disclosed Holdings

Weights are based on the information table value in the latest imported filing.

Ticker	Company	Weight	Shares	Market value	Sector
PLTR	Palantir Technologies Inc. CUSIP 69608A108	66.0%	5,000,000	912,100,000,000	Technology
NVDA	NVIDIA Corporation CUSIP 67066G104	13.5%	1,000,000	186,580,000,000	Technology
PFE	Pfizer Inc CUSIP 717081103	11.1%	6,000,000	152,880,000,000	Healthcare
HAL	Halliburton Company CUSIP 406216101	4.5%	2,500,000	61,500,000,000	Energy
MOH	Molina Healthcare Inc CUSIP 60855R100	1.7%	125,000	23,920,000,000	Healthcare
LULU	Lululemon Athletica Inc CUSIP 550021109	1.3%	100,000	17,793,000,000	Consumer Cyclical
SLM	SLM Corp CUSIP 78442P106	1.0%	480,054	13,287,895,000	Financial Services
BRKR	Bruker Corporation CUSIP 116794207	1.0%	48,334	13,137,181,000	Healthcare

Research and Risk Disclosure

This page is for informational research and decision support only. It is not personalized financial advice and does not say that any user should buy or sell a security. 13F investor data reflects last disclosed public filings and may be delayed, incomplete, amended, or no longer current. Strategy returns are historical model output or live tracking only when explicitly marked live. Review benchmark, time period, rebalancing frequency, data assumptions, fees, slippage, drawdown, and survivorship-bias handling before relying on any performance comparison.